SHP2 Inhibition Reveals Compensatory PI3K-AKT Activation in KRAS-Driven Pancreatic Cancer: Discovery of SDUY104 and Rational Approaches for Combination Therapy.

buparlisib (AN2025) - Adlai Nortye

ulixertinib (BVD-523) - BioMed Valley Discoveries

http://www.ncbi.nlm.nih.gov/pubmed/42261691

Chen Wang; Chengchun Zhu; Jinbo Yue; Kai Chen; Naining Zhang; Ruirong Tan; Xiaohan Ye; Xiaoyu Liu; Yang Lin; Yang Zhang; Yaran Jin; Yijie Zhu; Zhiyi Yu; Zongrui Yu

Jun 10, 2026